(Reuters) – Merck and Co said on Tuesday it was planning to produce and donate vials of investigational Sudan ebolavirus vaccine to IAVI for the global non-profit organization’s research program in Uganda.
The organization aims to address urgent, unmet global health challenges including HIV, tuberculosis and emerging infectious diseases.
(Reporting by Leroy Leo in Bengaluru; Editing by Arun Koyyur)
